NOT KNOWN DETAILS ABOUT DCK DRUG

We subsequently made a more precise probe, [18F]CFA, which was Employed in The present study To judge dCK exercise in tumors when taken care of with a little molecule dCK inhibitor. This probe can be currently being examined in the clinical trial at our institution To judge improvements in dCK activity subsequent cancer immunotherapy eighteen. PET